The above data provide strong evidence identifying SK1 as an important downstream target of the tumor‐promoting activity in p53‐null mice, although many questions still remain as to the exact mechanism of SK1 proteolysis in cancer cells in response to DNA damage, and whether this pathway is perturbed in p53‐mutant cells. The gene discussed is TP53; the disease is neoplasm.